Ultra-Trace Analysis of Cyanotoxins by Liquid Chromatography Coupled to High-Resolution Mass Spectrometry.
Daria FilatovaOscar NuñezMarinella FarréPublished in: Toxins (2020)
The increasing frequency of episodes of harmful algal blooms of cyanobacterial origin is a risk to ecosystems and human health. The main human hazard may arise from drinking water supply and recreational water use. For this reason, efficient multiclass analytical methods are needed to assess the level of cyanotoxins in water reservoirs and tackle these problems. This work describes the development of a fast, sensitive, and robust analytical method for multiclass cyanotoxins determination based on dual solid-phase extraction (SPE) procedure using a polymeric cartridge, Oasis HLB (Waters Corporation, Milford, MA, USA), and a graphitized non-porous carbon cartridge, SupelcleanTM ENVI-CarbTM (Sigma-Aldrich, St. Louis, MO, USA), followed by ultra-high-performance liquid chromatography high-resolution mass spectrometry (SPE-UHPLC-HRMS). This method enabled the analysis of cylindrospermopsin, anatoxin-a, nodularin, and seven microcystins (MC-LR, MC-RR, MC-YR, MC-LA, MC-LY, MC-LW, MC-LF). The method limits of detection (MLOD) of the validated approach were between 4 and 150 pg/L. The analytical method was applied to assess the presence of the selected toxins in 21 samples collected in three natural water reservoirs in the Ter River in Catalonia (NE of Spain) used to produce drinking water for Barcelona city (Spain).
Keyphrases
- liquid chromatography
- high resolution mass spectrometry
- solid phase extraction
- ultra high performance liquid chromatography
- drinking water
- tandem mass spectrometry
- mass spectrometry
- high performance liquid chromatography
- molecularly imprinted
- simultaneous determination
- liquid chromatography tandem mass spectrometry
- gas chromatography
- gas chromatography mass spectrometry
- human health
- health risk assessment
- risk assessment
- health risk
- climate change
- high resolution
- endothelial cells
- ms ms
- drug delivery
- minimally invasive